Superworth

Iradimed IRMD

Medical - Instruments & Supplies, Healthcare
$79.42
+3.57%
Market cap
$1B
PE
42.5×
10y median 41.5×
Forward PE
n/m
not a meaningful number
Price to sales
11.4×
EV/EBIT
34.7×
Revenue, 12 months
$89.3M
+11% on a year ago
Net margin
26.8%
Free cash flow yield
2.6%

Iradimed trades at 42.5× trailing earnings, near its ten-year median. Revenue was $89.3M over the last twelve months, up 11% on a year earlier with a 27% net margin.

Charts

Financials

Income statement for IRMD, by quarter
Income statementQ4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
$17.5M+17%$17.6M+14%$17.9M+11%$18.3M+11%$19.4M+11%$19.5M+11%$20.4M+14%$21.2M+16%$22.7M+17%$22M+13%$20.5M+0%$24.2M+14%
Cost of revenue$4M+11%$4.2M+12%$3.9M−1%$4.1M+13%$4.6M+15%$4.7M+11%$4.5M+14%$4.7M+14%$5.7M+22%$5.2M+11%$5.3M+19%$5.7M+22%
Gross profit$13.4M+20%$13.4M+14%$14M+15%$14.2M+11%$14.8M+10%$14.8M+11%$16M+14%$16.5M+16%$17M+15%$16.8M+13%$15.2M−5%$18.5M+12%
R&D$650.4K+8%$821K−73%$801.1K−17%$639.5K+41%$570K−12%$624.2K−24%$877.4K+10%$674.4K+6%$799K+40%$956K+53%$657K−25%$875K+30%
SG&A$7.6M+20%$7.8M+66%$7.6M+21%$7.8M+20%$8.4M+10%$8.8M+12%$8.3M+9%$9M+16%$9.1M+9%$8.6M−2%$8.1M−2%$9.4M+5%
$5.2M+21%$4.7M+19%$5.6M+13%$5.8M−2%$5.8M+12%$5.4M+14%$6.8M+21%$6.8M+18%$7.1M+22%$7.2M+33%$6.4M−6%$8.1M+19%
Pre-tax income$5.7M+21%$5.2M+21%$6.3M+18%$6.4M+0%$6.3M+12%$5.9M+13%$7.3M+17%$7.3M+14%$7.8M+23%$7.8M+31%$6.9M−6%$8.7M+19%
$1.1M+11%$1.1M+17%$1.4M+22%$1.4M+2%$1.2M+5%$1.3M+14%$1.6M+14%$1.7M+26%$1.3M+13%$2M+55%$1.7M+8%$2.2M+26%
Net income$4.5M+24%$4.1M+21%$4.9M+17%$5M−0%$5.1M+13%$4.7M+13%$5.8M+18%$5.6M+10%$6.4M+25%$5.8M+24%$5.2M−10%$6.5M+17%
$0.36+24%$0.32+19%$0.38+15%$0.40+0%$0.40+11%$0.37+16%$0.45+18%$0.43+8%$0.50+25%$0.45+22%$0.41−9%$0.51+19%
12.7M+1%12.7M+1%12.8M+0%12.8M+0%12.8M+1%12.8M+1%12.8M+1%12.9M+1%12.9M+0%12.9M+0%12.9M+0%12.9M+0%

Revenue: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

Cost of revenue: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

Gross profit: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

R&D: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

SG&A: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

Operating income: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

Pre-tax income: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

Income tax: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

Net income: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.

EPS, diluted: 15 periods, Q1 FY13 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: Q1 FY13: share-days: the 6-month average less the second quarter's. 13 periods, Q4 FY13 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest Iradimed's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
IRMDIradimed$1B42.5×41.5×11.4×+11%26.8%
IARTIntegra Lifesciences$1.1B80.1×46.3×0.6×+1%0.8%
BVSBioventus$1.1B17.1×27.1×1.9×+4%9.4%
STAAStaar Surgical$1.3B356×144×3.7×+51%1.1%
CDRECadre$1.3B38.9×35.9×2.0×+20%5.3%
EYENational Vision$1.4B28.1×52.7×0.7×+8%2.5%
MOVMovado$710.9M17.7×13.4×1.0×+5%6.0%
LMATLemaitre Vascular$1.9B28.5×42.0×7.1×+12%25.0%
INSPInspire Medical Systems$1.9B14.5×56.6×2.2×−0%15.0%
TCMDTactile Systems Technology$518.1M21.2×62.3×1.5×+17%7.1%
UFPTUFP Technologies$2.2B30.6×25.6×3.5×+7%11.4%
Peer median$1.3B28.3×44.1×1.9×+8%6.5%

More on Iradimed

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .